Fischer Medical Ventures Reports Q2 FY27 Financial Results
Fischer Medical Ventures Ltd · Outcome · 15 Nov 2026, 5:09 am
Fischer Medical Ventures Reports Q2 FY27 Financial Results Fischer Medical Ventures posted consolidated revenue from operations of ₹10,743.65 lakhs for Q2 ended 30th Sep'26, up 24.50% YoY from ₹8,629.52 lakhs and 31.15% QoQ from ₹8,192.00 lakhs. Consolidated net profit for the quarter dropped sharply to ₹80.45 lakhs compared to ₹1,384.57 lakhs in Q2 ended 30th Sep'25, reflecting higher purchases of traded goods and tax outlays. For H1 ended 30th Sep'26, consolidated revenue surged 72.38% YoY to ₹18,935.64 lakhs, while net profit stood at ₹459.59 lakhs. Diluted EPS for the quarter was ₹0.01.
Original exchange filing (PDF)
More announcements from Fischer Medical Ventures Ltd
- Financial results for the quarter and half year ended 30th Sept 2026 · 15 Nov 2026
- Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 15 Nov 2026
- The Monitoring Agency Report for the quarter ended 30 September 2026 is enclosed. · 14 Nov 2026
- Fischer Medical Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone .... · 14 Nov 2026
- Appointment of Mr Chan Sing En as an Independent Director of FMV Global Innovations Pte.Ltd, Singapore, a Material Wholly Owned Subsidiary Company · 27 Oct 2026
- Postal Ballot Notice & Scrutinizer · 14 Oct 2026
